ConductScience.org, home

Paper23225543

Amyloid-β oligomerization in Alzheimer dementia versus high-pathology controls.

Esparza TJ and 6 others. Ann Neurol, 2013. Cited by 248 papers, by iCite.

Cite this record

ConductScience Library. Amyloid-β oligomerization in Alzheimer dementia versus high-pathology controls. Papers, record 23225543. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/23225543

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Amyloid-β oligomerization in Alzheimer dementia versus high-pathology controls.
PubMed
Journal
Ann Neurol
PubMed
Year
2013
PubMed
Publication types
Comparative Study, Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
248
iCite
Relative citation ratio, by iCite
7.96
iCite
Revised in PubMed
2024-11-19
PubMed

Authors7

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Esparza TJThomas J
2Zhao HHanzhi
3Cirrito JRJohn R
4Cairns NJNigel J
5Bateman RJRandall J
6Holtzman DMDavid M
7Brody DLDavid L

Source PubMed

Download CSV of authors

Topics8

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Alzheimer DiseaseMajor topic
Amyloid beta-PeptidesMajor topic
Cerebral CortexMajor topic
Aged, 80 and over
Female
Humans
Male
Protein Multimerization

Source PubMed

Download CSV of topics

Grants15

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated bySource
R-01-NS065667NINDS NIH HHSUnited StatesR01NS065667PubMed and NIHNIH RePORTER
R01 AG013956NIA NIH HHSUnited StatesR01AG013956PubMed and NIHNIH RePORTER
R01 NS065667NINDS NIH HHSUnited StatesR01NS065667PubMed and NIHNIH RePORTER
P50 AG005681NIA NIH HHSUnited StatesP50AG005681PubMed and NIHNIH RePORTER
AG13956NIA NIH HHSUnited StatesR01AG013956PubMed and NIHNIH RePORTER
K-23-AG030946NIA NIH HHSUnited StatesK23AG030946PubMed and NIHNIH RePORTER
R37 AG013956NIA NIH HHSUnited StatesR01AG013956PubMed and NIHNIH RePORTER
K08 NS049237NINDS NIH HHSUnited StatesK08NS049237PubMed and NIHNIH RePORTER
P50-AG05681NIA NIH HHSUnited StatesP50AG005681PubMed and NIHNIH RePORTER
AG029524NIA NIH HHSUnited StatesK01AG029524PubMed and NIHNIH RePORTER
R01 NS065069NINDS NIH HHSUnited StatesR01NS065069PubMed and NIHNIH RePORTER
P01-AG03991NIA NIH HHSUnited StatesP01AG003991PubMed and NIHNIH RePORTER
P30 NS057105NINDS NIH HHSUnited StatesP30NS057105PubMed and NIHNIH RePORTER
K01 AG029524NIA NIH HHSUnited StatesK01AG029524PubMed and NIHNIH RePORTER
R37AG013956NIHNIH RePORTER

Download CSV of grants

References53

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
19600986Diffusible, nonfibrillar ligands derived from Abeta1-42 are potent central nervous system neurotoxins.Proc Natl Acad Sci U S A1998https://conductscience.org/library/papers/9600986PubMed
29395306Hemin and related porphyrins inhibit beta-amyloid aggregation.FEBS Lett1997https://conductscience.org/library/papers/9395306PubMed
320682338Traumatic brain injury reduces soluble extracellular amyloid-β in mice: a methodologically novel combined microdialysis-controlled cortical impact study.Neurobiol Dis2010https://conductscience.org/library/papers/20682338PubMed
49862640Neuropathological and neuropsychological changes in "normal" aging: evidence for preclinical Alzheimer disease in cognitively normal individuals.J Neuropathol Exp Neurol1998https://conductscience.org/library/papers/9862640PubMed
57857653Dominant and differential deposition of distinct beta-amyloid peptide species, A beta N3(pE), in senile plaques.Neuron1995https://conductscience.org/library/papers/7857653PubMed
619523517Soluble fibrillar oligomer levels are elevated in Alzheimer's disease brain and correlate with cognitive dysfunction.Neurobiol Dis2009https://conductscience.org/library/papers/19523517PubMed
712925731Alzheimer's disease-affected brain: presence of oligomeric A beta ligands (ADDLs) suggests a molecular basis for reversible memory loss.Proc Natl Acad Sci U S A2003https://conductscience.org/library/papers/12925731PubMed
818417702Amyloid beta protein dimer-containing human CSF disrupts synaptic plasticity: prevention by systemic passive immunization.J Neurosci2008https://conductscience.org/library/papers/18417702PubMed
917116235Monoclonal antibodies that target pathological assemblies of Abeta.J Neurochem2007https://conductscience.org/library/papers/17116235PubMed
1010072051Tangles and plaques in nondemented aging and "preclinical" Alzheimer's disease.Ann Neurol1999https://conductscience.org/library/papers/10072051PubMed
1119001171Frequent amyloid deposition without significant cognitive impairment among the elderly.Arch Neurol2008https://conductscience.org/library/papers/19001171PubMed
1216469784Effects of secreted oligomers of amyloid beta-protein on hippocampal synaptic plasticity: a potent role for trimers.J Physiol2006https://conductscience.org/library/papers/16469784PubMed
1319376612Neuropathology of nondemented aging: presumptive evidence for preclinical Alzheimer disease.Neurobiol Aging2009https://conductscience.org/library/papers/19376612PubMed
1419228947Oligomeric amyloid beta associates with postsynaptic densities and correlates with excitatory synapse loss near senile plaques.Proc Natl Acad Sci U S A2009https://conductscience.org/library/papers/19228947PubMed
1518824027Characterisation of two antibodies to oligomeric Abeta and their use in ELISAs on human brain tissue homogenates.J Neurosci Methods2009https://conductscience.org/library/papers/18824027PubMed
1617623042Sensitive ELISA detection of amyloid-beta protofibrils in biological samples.J Neurochem2007https://conductscience.org/library/papers/17623042PubMed
1710950879X-34, a fluorescent derivative of Congo red: a novel histochemical stain for Alzheimer's disease pathology.J Histochem Cytochem2000https://conductscience.org/library/papers/10950879PubMed
1812058030Oligomeric and fibrillar species of amyloid-beta peptides differentially affect neuronal viability.J Biol Chem2002https://conductscience.org/library/papers/12058030PubMed
1920685980Generation and therapeutic efficacy of highly oligomer-specific beta-amyloid antibodies.J Neurosci2010https://conductscience.org/library/papers/20685980PubMed
2014661937Recommendations for the bioanalytical method validation of ligand-binding assays to support pharmacokinetic assessments of macromolecules.Pharm Res2003https://conductscience.org/library/papers/14661937PubMed

See all 53 referencesDownload CSV of references

Cited by176

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 248 citations.

PMIDTitleJournalYearIn PapersSource
42720909Amyloid-β PET Radioligands in Alzheimer's Disease: From Plaque Detection to Biomarker-Guided Patient Stratification and Therapeutic Monitoring.Mol Diagn Ther2026https://conductscience.org/library/papers/42720909PubMed
42660456Apolipoprotein E lipidation, rather than isoform identity, determines amyloid-β binding and astrocyte clearance.J Biol Chem2026https://conductscience.org/library/papers/42660456PubMed
42377771Investigating a relation between amyloid beta plaque burden and accumulated neurotoxicity caused by amyloid beta oligomers.Med Biol Eng Comput2026https://conductscience.org/library/papers/42377771PubMed
42282610Aβ Aggregates Bind the U1 Spliceosomal Ribonucleoprotein in Alzheimer Disease Brain.bioRxiv2026https://conductscience.org/library/papers/42282610PubMed
42141350Amyloid Plaques Ameliorate Memory Deficits and Hippocampal Neuron Loss in an Aβ4-42-Driven Alzheimer's Disease Mouse Model.Mol Neurobiol2026https://conductscience.org/library/papers/42141350PubMed
41981185Anti-amyloid antibody equilibrium binding to Aβ aggregates from human Alzheimer's disease brain.Alzheimers Dement2026https://conductscience.org/library/papers/41981185PubMed
41820797In vitro, cellular and in vivo studies of amyloid oligomers structure and toxicity: Challenges and advances.Protein Sci2026https://conductscience.org/library/papers/41820797PubMed
40864225Donepezil and Memantine Derivatives for Dual-Function and Prodrug Applications in Alzheimer's Disease.ACS Chem Neurosci2025https://conductscience.org/library/papers/40864225PubMed
40828109Sulfopropanoic acid derivatives for treating neurodegenerative disorders: a patent spotlight.Pharm Pat Anal2024https://conductscience.org/library/papers/40828109PubMed
40646564An improved immunoassay detects Aβ oligomers in human biofluids: their CSF levels rise with tau and phosphotau levels.Alzheimers Res Ther2025https://conductscience.org/library/papers/40646564PubMed
40584900The promise of gene therapy in common types of dementia.Bioimpacts2025https://conductscience.org/library/papers/40584900PubMed
40509358N-Alkylamino Stilbene Compounds as Amyloid β Inhibitors for Alzheimer's Disease Research.Molecules2025https://conductscience.org/library/papers/40509358PubMed
40136948Recent Advances in Electrochemical Biosensors for Neurodegenerative Disease Biomarkers.Biosensors (Basel)2025https://conductscience.org/library/papers/40136948PubMed
40030015Inhibition of amyloid beta oligomer accumulation by NU-9: A unifying mechanism for the treatment of neurodegenerative diseases.Proc Natl Acad Sci U S A2025https://conductscience.org/library/papers/40030015PubMed
39939821Soluble cerebral Aβ protofibrils link Aβ plaque pathology to changes in CSF Aβ42/Aβ40 ratios, neurofilament light and tau in Alzheimer's disease model mice.Nat Aging2025https://conductscience.org/library/papers/39939821PubMed
39726673Monoclonal Antibody Treatments for Alzheimer's Disease: Aducanumab and Lecanemab.Discoveries (Craiova)2023https://conductscience.org/library/papers/39726673PubMed
39013601Somatostatin: Linking Cognition and Alzheimer Disease to Therapeutic Targeting.Pharmacol Rev2024https://conductscience.org/library/papers/39013601PubMed
38992064Targeting soluble amyloid-beta oligomers with a novel nanobody.Sci Rep2024https://conductscience.org/library/papers/38992064PubMed
38916729Tryptophan Metabolism in Alzheimer's Disease with the Involvement of Microglia and Astrocyte Crosstalk and Gut-Brain Axis.Aging Dis2024https://conductscience.org/library/papers/38916729PubMed
38902572
Analysis of Cerebrospinal Fluid, Plasma β-Amyloid Biomarkers, and Cognition from a 2-Year Phase 2 Trial Evaluating Oral ALZ-801/Valiltramiprosate in APOE4 Carriers with Early Alzheimer's Disease Using Quantitative Systems Pharmacology Model.
Drugs2024https://conductscience.org/library/papers/38902572PubMed

See all 176 cited byDownload CSV of cited by

Genes5

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
APOE348PubTator's text mininghttps://conductscience.org/library/genes/348NCBI Gene
APP351PubTator's text mininghttps://conductscience.org/library/genes/351NCBI Gene
MAPT4137PubTator's text mininghttps://conductscience.org/library/genes/4137NCBI Gene
MB4151PubTator's text mininghttps://conductscience.org/library/genes/4151NCBI Gene
TG7038PubTator's text mininghttps://conductscience.org/library/genes/7038NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/23225543

GET https://conductscience.org/api/papers/v1/23225543/references?page=2